Condensed Consolidated Statements of Cash Flows $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)
OPERATING ACTIVITIES:
Net income	$ 449	$ 461
Adjustments to net income:
Depreciation and amortization	926	836
Gain (loss) on disposal and sale of business interests	(43)	4
Impairment expense	355	358
Deferred income tax expense (benefit), net of tax credit transfers	423	(102)
Emissions Allowance Expense	144	211
Loss on realized/unrealized foreign currency	92	184
Other	81	118
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(576)	16
(Increase) decrease in inventory	58	253
(Increase) decrease in prepaid expenses and other current assets	120	76
(Increase) decrease in other assets	177	(4)
Increase (decrease) in accounts payable and other current liabilities	34	(187)
Increase (decrease) in income tax payables, net and other tax payables	(514)	(67)
Increase (decrease) in other liabilities	132	73
Net cash provided by operating activities	1,664	2,309
INVESTING ACTIVITIES:
Capital expenditures	(5,665)	(5,295)
Payments to Acquire Businesses and Interest in Affiliates	79	311
Proceeds from Divestiture of Businesses and Interests in Affiliates	11	98
Sale of short-term investments	731	1,002
Purchase of short-term investments	(725)	(764)
Contributions and loans to equity affiliates	(71)	(147)
Payments to Acquire Intangible Assets	(157)	(161)
Other investing	(134)	(95)
Net cash used in investing activities	(6,089)	(5,673)
FINANCING ACTIVITIES:
Borrowings under the revolving credit facilities	5,652	3,939
Repayments under the revolving credit facilities	(4,051)	(2,730)
Proceeds from (Repayments of) Commercial Paper	611	604
Issuance of recourse debt	950	1,400
Issuance of non-recourse debt	5,199	1,784
Repayments of non-recourse debt	(3,311)	(1,262)
Payments for financing fees	(88)	(76)
Purchases under supplier financing arrangements	(1,211)	(1,307)
Repayments of obligations under supplier financing arrangements	1,412	1,099
Distributions to noncontrolling interests	(165)	(173)
Contributions from noncontrolling interests	137	63
Sales to Noncontrolling Interests	869	371
Dividends paid on AES common stock	(361)	(333)
Payments for financed capital expenditures	(29)	(8)
Other financing	(25)	(47)
Net cash provided by financing activities	5,187	3,740
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(47)	(108)
Net Cash Change Of Discontinued And Held For Sale Businesses	(146)	(20)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	569	248
Cash, cash equivalents and restricted cash, beginning	1,990	2,087
Cash, cash equivalents and restricted cash, ending	2,559	2,335
SUPPLEMENTAL DISCLOSURES:
Cash payments for interest, net of amounts capitalized	1,103	735
Cash payments for income taxes, net of refunds	270	267
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Noncash or Part Noncash Divestiture, Amount of Consideration Received	14	215
Lease Obligation Incurred	240	187
Conversion of Stock, Amount Converted	838	0
Liability derecognized due to sale of assets	273
Non-cash contributions from noncontrolling interests	213	60
Other current assets, net of allowance of $0 and $14, respectively	1,460
Loss (gain) on realized/unrealized derivatives	(194)	$ 79
Warrior Run
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Liability derecognized due to sale of assets	$ 260

AES CORP 10-Q